DAVID C HASTINGS Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for DAVID C HASTINGS.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of DAVID C HASTINGS. DAVID C HASTINGS is Exec VP & CFO in INCYTE CORP ($INCY) and Director in SCYNEXIS INC ($SCYX) and Chief Financial Officer in Arbutus Biopharma Corp ($TKMR) and See Remarks in Unilife Corp ($UNIS) and Director in Entasis Therapeutics Holdings Inc. ($ETTX).
Latest Insider Trading Transactions of DAVID C HASTINGS
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, TKMR, ETTX, INCY, SCYX, UNIS
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 02 2021 | ETTX | Entasis Therapeuti ... | HASTINGS DAVID C | Director | Grant | A | 0.00 | 22,000 | 0 | 22,000 | 0 to 22 K |
| Feb 17 2021 | TKMR | Arbutus Biopharma ... | HASTINGS DAVID C | Chief Financial Off ... | Option Exercise | A | 4.33 | 250,000 | 1,082,500 | 250,000 | |
| Oct 06 2020 | ETTX | Entasis Therapeuti ... | HASTINGS DAVID C | Director | Option Exercise | A | 2.98 | 11,000 | 32,780 | 11,000 | |
| Jul 08 2020 | SCYX | SCYNEXIS INC | HASTINGS DAVID C | Director | Option Exercise | A | 0.73 | 45,000 | 32,850 | 45,000 | |
| Feb 19 2020 | TKMR | Arbutus Biopharma ... | HASTINGS DAVID C | Chief Financial Off ... | Option Exercise | A | 3.35 | 100,000 | 335,000 | 100,000 | |
| Jun 21 2019 | ETTX | Entasis Therapeuti ... | HASTINGS DAVID C | Director | Option Exercise | A | 6.12 | 7,500 | 45,900 | 7,500 | |
| Jun 20 2019 | SCYX | SCYNEXIS INC | HASTINGS DAVID C | Director | Option Exercise | A | 1.29 | 45,000 | 58,050 | 45,000 | |
| Jan 22 2019 | ETTX | Entasis Therapeuti ... | HASTINGS DAVID C | Director | Option Exercise | A | 5.66 | 15,000 | 84,900 | 15,000 | |
| Jan 04 2019 | SCYX | SCYNEXIS INC | HASTINGS DAVID C | Director | Option Exercise | A | 0.54 | 22,500 | 12,242 | 22,500 | |
| Jun 21 2018 | TKMR | Arbutus Biopharma ... | HASTINGS DAVID C | Chief Financial Off ... | Option Exercise | A | 6.75 | 200,000 | 1,350,000 | 200,000 | |
| Mar 12 2018 | SCYX | SCYNEXIS INC | HASTINGS DAVID C | Director | Option Exercise | P | 2.00 | 5,325 | 10,650 | 5,325 | |
| Mar 12 2018 | SCYX | SCYNEXIS INC | HASTINGS DAVID C | Director | Option Exercise | P | 1.85 | 8,875 | 16,419 | 8,875 | |
| Mar 12 2018 | SCYX | SCYNEXIS INC | HASTINGS DAVID C | Director | Buy | P | 1.69 | 11,834 | 19,999 | 31,834 | 20 K to 31.8 K (+59.17 %) |
| Jan 04 2018 | SCYX | SCYNEXIS INC | HASTINGS DAVID C | Director | Option Exercise | A | 2.28 | 19,989 | 45,575 | 19,989 | |
| Jun 22 2017 | SCYX | SCYNEXIS INC | HASTINGS DAVID C | Director | Buy | P | 1.75 | 20,000 | 35,000 | 20,000 | 0 to 20 K |
| Jun 22 2017 | SCYX | SCYNEXIS INC | HASTINGS DAVID C | Director | Buy | P | 1.75 | 20,000 | 35,000 | 20,000 | 0 to 20 K |
| Jan 30 2017 | UNIS | Unilife Corp | HASTINGS DAVID C | See Remarks | Option Exercise | A | 2.53 | 150,000 | 379,500 | 150,000 | |
| Jan 05 2017 | SCYX | SCYNEXIS INC | HASTINGS DAVID C | Director | Option Exercise | A | 3.40 | 14,499 | 49,297 | 14,499 | |
| Jun 06 2016 | SCYX | SCYNEXIS INC | HASTINGS DAVID C | Director | Option Exercise | A | 3.98 | 8,800 | 35,024 | 8,800 | |
| Sep 28 2015 | SCYX | SCYNEXIS INC | HASTINGS DAVID C | Director | Option Exercise | A | 6.89 | 11,700 | 80,613 | 11,700 | |
| Feb 25 2015 | UNIS | Unilife Corp | HASTINGS DAVID C | See Remarks | Grant | A | 0.00 | 300,000 | 0 | 300,000 | 0 to 300 K |
| Feb 18 2004 | INCY | INCYTE CORP | HASTINGS DAVID C | Exec VP & CFO | Option Exercise | A | 8.19 | 9,583 | 78,485 | 9,583 | |
| Feb 18 2004 | INCY | INCYTE CORP | HASTINGS DAVID C | Exec VP & CFO | Option Exercise | A | 8.19 | 417 | 3,415 | 417 |
Page: 1